CG Oncology (CGON) Earnings Date & Reports

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CGON is expected to report earnings to fall 15.49% to -60 cents per share on November 12

Q3'26

Est.

$-0.60

Q1'26

Missed

by $0.11

Q4'25

Missed

by $0.07

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.12

The last earnings report on May 08 showed earnings per share of -70 cents, missing the estimate of -60 cents. With 330.90K shares outstanding, the current market capitalization sits at 7.07B.

View a ticker or compare two or three

Ask AI

Compare

NEWBiotechnologies - Trading Results
AI Trading Agent, 60min NEWBiotechnologies - Trading Results
AI Trading Agent, 60min

Annualized Return+61%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CGON

Setup

Daily Signal:

Description

Gain/Loss: